| UniProt ID | LAMA4_HUMAN | |
|---|---|---|
| UniProt AC | Q16363 | |
| Protein Name | Laminin subunit alpha-4 | |
| Gene Name | LAMA4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1823 | |
| Subcellular Localization | Secreted, extracellular space, extracellular matrix, basement membrane. Major component. | |
| Protein Description | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.. | |
| Protein Sequence | MALSSAWRSVLPLWLLWSAACSRAASGDDNAFPFDIEGSSAVGRQDPPETSEPRVALGRLPPAAEKCNAGFFHTLSGECVPCDCNGNSNECLDGSGYCVHCQRNTTGEHCEKCLDGYIGDSIRGAPQFCQPCPCPLPHLANFAESCYRKNGAVRCICNENYAGPNCERCAPGYYGNPLLIGSTCKKCDCSGNSDPNLIFEDCDEVTGQCRNCLRNTTGFKCERCAPGYYGDARIAKNCAVCNCGGGPCDSVTGECLEEGFEPPTGMDCPTISCDKCVWDLTDALRLAALSIEEGKSGVLSVSSGAAAHRHVNEINATIYLLKTKLSERENQYALRKIQINNAENTMKSLLSDVEELVEKENQASRKGQLVQKESMDTINHASQLVEQAHDMRDKIQEINNKMLYYGEEHELSPKEISEKLVLAQKMLEEIRSRQPFFTQRELVDEEADEAYELLSQAESWQRLHNETRTLFPVVLEQLDDYNAKLSDLQEALDQALNYVRDAEDMNRATAARQRDHEKQQERVREQMEVVNMSLSTSADSLTTPRLTLSELDDIIKNASGIYAEIDGAKSELQVKLSNLSNLSHDLVQEAIDHAQDLQQEANELSRKLHSSDMNGLVQKALDASNVYENIVNYVSEANETAEFALNTTDRIYDAVSGIDTQIIYHKDESENLLNQARELQAKAESSSDEAVADTSRRVGGALARKSALKTRLSDAVKQLQAAERGDAQQRLGQSRLITEEANRTTMEVQQATAPMANNLTNWSQNLQHFDSSAYNTAVNSARDAVRNLTEVVPQLLDQLRTVEQKRPASNVSASIQRIRELIAQTRSVASKIQVSMMFDGQSAVEVHSRTSMDDLKAFTSLSLYMKPPVKRPELTETADQFILYLGSKNAKKEYMGLAIKNDNLVYVYNLGTKDVEIPLDSKPVSSWPAYFSIVKIERVGKHGKVFLTVPSLSSTAEEKFIKKGEFSGDDSLLDLDPEDTVFYVGGVPSNFKLPTSLNLPGFVGCLELATLNNDVISLYNFKHIYNMDPSTSVPCARDKLAFTQSRAASYFFDGSGYAVVRDITRRGKFGQVTRFDIEVRTPADNGLILLMVNGSMFFRLEMRNGYLHVFYDFGFSGGPVHLEDTLKKAQINDAKYHEISIIYHNDKKMILVVDRRHVKSMDNEKMKIPFTDIYIGGAPPEILQSRALRAHLPLDINFRGCMKGFQFQKKDFNLLEQTETLGVGYGCPEDSLISRRAYFNGQSFIASIQKISFFDGFEGGFNFRTLQPNGLLFYYASGSDVFSISLDNGTVIMDVKGIKVQSVDKQYNDGLSHFVISSVSPTRYELIVDKSRVGSKNPTKGKIEQTQASEKKFYFGGSPISAQYANFTGCISNAYFTRVDRDVEVEDFQRYTEKVHTSLYECPIESSPLFLLHKKGKNLSKPKASQNKKGGKSKDAPSWDPVALKLPERNTPRNSHCHLSNSPRAIEHAYQYGGTANSRQEFEHLKGDFGAKSQFSIRLRTRSSHGMIFYVSDQEENDFMTLFLAHGRLVYMFNVGHKKLKIRSQEKYNDGLWHDVIFIRERSSGRLVIDGLRVLEESLPPTEATWKIKGPIYLGGVAPGKAVKNVQINSIYSFSGCLSNLQLNGASITSASQTFSVTPCFEGPMETGTYFSTEGGYVVLDESFNIGLKFEIAFEVRPRSSSGTLVHGHSVNGEYLNVHMKNGQVIVKVNNGIRDFSTSVTPKQSLCDGRWHRITVIRDSNVVQLDVDSEVNHVVGPLNPKPIDHREPVFVGGVPESLLTPRLAPSKPFTGCIRHFVIDGHPVSFSKAALVSGAVSINSCPAA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 104 | N-linked_Glycosylation | YCVHCQRNTTGEHCE EEEECCCCCCCCHHH | 19.00 | UniProtKB CARBOHYD | |
| 117 (in isoform 3) | Phosphorylation | - | 11.03 | 26503514 | |
| 215 | N-linked_Glycosylation | QCRNCLRNTTGFKCE HHHHHHHHCCCCCCE | 29.10 | UniProtKB CARBOHYD | |
| 264 | O-linked_Glycosylation | EEGFEPPTGMDCPTI HCCCCCCCCCCCCCC | 56.72 | OGP | |
| 290 | Phosphorylation | ALRLAALSIEEGKSG HHHHHHHHHHCCCCC | 24.19 | 27499020 | |
| 296 | Phosphorylation | LSIEEGKSGVLSVSS HHHHCCCCCEEEECC | 45.02 | - | |
| 300 | Phosphorylation | EGKSGVLSVSSGAAA CCCCCEEEECCHHHH | 19.97 | - | |
| 303 | Phosphorylation | SGVLSVSSGAAAHRH CCEEEECCHHHHHHH | 30.23 | - | |
| 315 | N-linked_Glycosylation | HRHVNEINATIYLLK HHHHHHHHHHEEHHH | 25.50 | UniProtKB CARBOHYD | |
| 317 | Phosphorylation | HVNEINATIYLLKTK HHHHHHHHEEHHHHC | 12.98 | - | |
| 319 | Phosphorylation | NEINATIYLLKTKLS HHHHHHEEHHHHCCC | 11.13 | 22817900 | |
| 323 | Phosphorylation | ATIYLLKTKLSEREN HHEEHHHHCCCHHHH | 36.87 | - | |
| 332 | Phosphorylation | LSERENQYALRKIQI CCHHHHHHHHHHHHC | 21.13 | 22817900 | |
| 351 | Phosphorylation | NTMKSLLSDVEELVE HHHHHHHHHHHHHHH | 44.92 | - | |
| 412 | Phosphorylation | YGEEHELSPKEISEK CCCCCCCCHHHHHHH | 30.82 | 28111955 | |
| 465 | N-linked_Glycosylation | ESWQRLHNETRTLFP HHHHHHHHHHHHHHH | 57.85 | UniProtKB CARBOHYD | |
| 531 | N-linked_Glycosylation | REQMEVVNMSLSTSA HHHHHHHHHHHCCCC | 21.36 | UniProtKB CARBOHYD | |
| 542 | Phosphorylation | STSADSLTTPRLTLS CCCCCCCCCCCCCHH | 38.41 | 24719451 | |
| 557 | N-linked_Glycosylation | ELDDIIKNASGIYAE HHHHHHHHCCCEEEE | 29.00 | 19159218 | |
| 578 | N-linked_Glycosylation | ELQVKLSNLSNLSHD HHHHHHHHHHCCCHH | 58.90 | 19159218 | |
| 581 | N-linked_Glycosylation | VKLSNLSNLSHDLVQ HHHHHHHCCCHHHHH | 49.05 | 19159218 | |
| 610 | Phosphorylation | ELSRKLHSSDMNGLV HHHHHHHHCCHHHHH | 38.17 | 29083192 | |
| 611 | Phosphorylation | LSRKLHSSDMNGLVQ HHHHHHHCCHHHHHH | 30.08 | 29083192 | |
| 638 | N-linked_Glycosylation | VNYVSEANETAEFAL HHHHHHCCHHHHHHH | 43.00 | UniProtKB CARBOHYD | |
| 646 | N-linked_Glycosylation | ETAEFALNTTDRIYD HHHHHHHCCCCHHHH | 37.19 | UniProtKB CARBOHYD | |
| 734 | Phosphorylation | AQQRLGQSRLITEEA HHHHHHHHHHHHHHH | 27.53 | 26074081 | |
| 742 | N-linked_Glycosylation | RLITEEANRTTMEVQ HHHHHHHHHHHHHHH | 45.15 | 19159218 | |
| 744 | Phosphorylation | ITEEANRTTMEVQQA HHHHHHHHHHHHHHH | 30.24 | 22210691 | |
| 758 | N-linked_Glycosylation | ATAPMANNLTNWSQN HHHCCCCCCCCHHHH | 38.41 | UniProtKB CARBOHYD | |
| 760 | Phosphorylation | APMANNLTNWSQNLQ HCCCCCCCCHHHHHH | 36.44 | 22210691 | |
| 761 | N-linked_Glycosylation | PMANNLTNWSQNLQH CCCCCCCCHHHHHHH | 39.30 | UniProtKB CARBOHYD | |
| 780 | Phosphorylation | AYNTAVNSARDAVRN HHHHHHHHHHHHHHH | 20.34 | 22210691 | |
| 787 | N-linked_Glycosylation | SARDAVRNLTEVVPQ HHHHHHHHHHHHHHH | 44.72 | 19159218 | |
| 810 | N-linked_Glycosylation | EQKRPASNVSASIQR HHHCCCCCCHHHHHH | 33.59 | 19159218 | |
| 851 | Phosphorylation | VEVHSRTSMDDLKAF EEEECCCCHHHHHHH | 21.07 | 24719451 | |
| 859 | Phosphorylation | MDDLKAFTSLSLYMK HHHHHHHHEEHHCCC | 33.35 | 24719451 | |
| 862 | Phosphorylation | LKAFTSLSLYMKPPV HHHHHEEHHCCCCCC | 19.74 | 24719451 | |
| 894 | Phosphorylation | SKNAKKEYMGLAIKN CCCCCCCEEEEEEEC | 12.83 | 22817900 | |
| 925 | Phosphorylation | PLDSKPVSSWPAYFS CCCCCCCCCCCEEEE | 34.90 | 23909892 | |
| 926 | Phosphorylation | LDSKPVSSWPAYFSI CCCCCCCCCCEEEEE | 36.99 | 23909892 | |
| 930 | Phosphorylation | PVSSWPAYFSIVKIE CCCCCCEEEEEEEEE | 8.19 | 23909892 | |
| 932 | Phosphorylation | SSWPAYFSIVKIERV CCCCEEEEEEEEEEE | 17.50 | 23909892 | |
| 951 | Phosphorylation | KVFLTVPSLSSTAEE EEEEECCCCCCCHHH | 36.23 | 28857561 | |
| 953 | Phosphorylation | FLTVPSLSSTAEEKF EEECCCCCCCHHHHH | 29.94 | 29691806 | |
| 954 | Phosphorylation | LTVPSLSSTAEEKFI EECCCCCCCHHHHHH | 36.61 | 26657352 | |
| 955 | Phosphorylation | TVPSLSSTAEEKFIK ECCCCCCCHHHHHHH | 34.41 | 28857561 | |
| 1045 | Phosphorylation | DKLAFTQSRAASYFF HCCEECCHHHHHHHC | 22.34 | 22210691 | |
| 1050 | Phosphorylation | TQSRAASYFFDGSGY CCHHHHHHHCCCCCE | 11.98 | 22210691 | |
| 1081 | Phosphorylation | RFDIEVRTPADNGLI EEEEEEECCCCCCEE | 28.18 | - | |
| 1093 | N-linked_Glycosylation | GLILLMVNGSMFFRL CEEEEEECCEEEEEE | 23.90 | UniProtKB CARBOHYD | |
| 1143 | Phosphorylation | YHEISIIYHNDKKMI CEEEEEEEECCCEEE | 7.90 | 27642862 | |
| 1171 | Phosphorylation | EKMKIPFTDIYIGGA CCCCCCCCEEEECCC | 19.01 | - | |
| 1231 | Phosphorylation | GYGCPEDSLISRRAY CCCCCCCCCCCCEEE | 26.41 | 24719451 | |
| 1234 | Phosphorylation | CPEDSLISRRAYFNG CCCCCCCCCEEECCC | 22.47 | 24719451 | |
| 1288 | N-linked_Glycosylation | VFSISLDNGTVIMDV EEEEECCCCEEEEEE | 54.02 | UniProtKB CARBOHYD | |
| 1307 | Phosphorylation | VQSVDKQYNDGLSHF EEEECCCCCCCCCCE | 22.44 | 22817900 | |
| 1312 | Phosphorylation | KQYNDGLSHFVISSV CCCCCCCCCEEEECC | 22.02 | 22817900 | |
| 1317 | Phosphorylation | GLSHFVISSVSPTRY CCCCEEEECCCCCEE | 21.27 | 22817900 | |
| 1324 | Phosphorylation | SSVSPTRYELIVDKS ECCCCCEEEEEEEHH | 19.98 | 22817900 | |
| 1366 | N-linked_Glycosylation | PISAQYANFTGCISN CCCHHHCCCCCCCCC | 30.03 | UniProtKB CARBOHYD | |
| 1418 | N-linked_Glycosylation | LLHKKGKNLSKPKAS EEECCCCCCCCCCHH | 59.21 | UniProtKB CARBOHYD | |
| 1420 | Phosphorylation | HKKGKNLSKPKASQN ECCCCCCCCCCHHCC | 57.20 | 24719451 | |
| 1563 | Phosphorylation | VIFIRERSSGRLVID EEEEEECCCCCEEEE | 32.18 | - | |
| 1578 | Phosphorylation | GLRVLEESLPPTEAT EEEHHHHCCCCCCCC | 36.48 | 26330541 | |
| 1582 | Phosphorylation | LEESLPPTEATWKIK HHHCCCCCCCCEEEE | 35.99 | 26330541 | |
| 1585 | Phosphorylation | SLPPTEATWKIKGPI CCCCCCCCEEEECCE | 22.51 | 26330541 | |
| 1593 | Phosphorylation | WKIKGPIYLGGVAPG EEEECCEEECCCCCC | 11.48 | 17924679 | |
| 1719 | Phosphorylation | GIRDFSTSVTPKQSL CCCCCCCCCCCCCHH | 23.85 | 24719451 | |
| 1725 | Phosphorylation | TSVTPKQSLCDGRWH CCCCCCCHHCCCCCE | 36.77 | 24719451 | |
| 1749 | Phosphorylation | VVQLDVDSEVNHVVG EEEEECCCCCCEECC | 43.20 | 22210691 | |
| 1804 | Phosphorylation | VIDGHPVSFSKAALV EECCCCCCCCHHHHH | 28.40 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LAMA4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LAMA4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LAMA4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CSN6_HUMAN | COPS6 | physical | 16169070 | |
| PTN_HUMAN | PTN | physical | 16169070 | |
| UBR1_HUMAN | UBR1 | physical | 16169070 | |
| ZHX1_HUMAN | ZHX1 | physical | 16169070 | |
| BRD7_HUMAN | BRD7 | physical | 16169070 | |
| MED31_HUMAN | MED31 | physical | 16169070 | |
| G3P_HUMAN | GAPDH | physical | 16169070 | |
| LRIF1_HUMAN | LRIF1 | physical | 16169070 | |
| P53_HUMAN | TP53 | physical | 16169070 | |
| TBB2A_HUMAN | TUBB2A | physical | 16169070 | |
| U119A_HUMAN | UNC119 | physical | 16169070 | |
| EF1A1_HUMAN | EEF1A1 | physical | 16169070 | |
| RTN4_HUMAN | RTN4 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615235 | Cardiomyopathy, dilated 1JJ (CMD1JJ) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-557; ASN-578; ASN-581;ASN-742; ASN-787 AND ASN-810, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1593, AND MASSSPECTROMETRY. | |